Association of Adiponectin, Resistin and High Sensitive CRP Level with the Metabolic Syndrome in Childhood and Adolescence

Abstract

Early markers are required in pathophysiological process of obesity, MS and type 2 diabetes. We aimed to clarify the usefulness of serum adipokines (adiponectin, AD and resistin) and inflammatory markers to identify obese and overweight children with MS. Three hundred and seven of 2 491 subjects aged 11–19 with BMI≥85 centile selected with a multistage, stratified sampling were included. Their height, weight and waist circumference were measured, all subjects underwent physical examination and standard OGTT. AD, resistin and hs-CRP were measured from baseline blood sample. The mean age of subjects was 14.2±1.8, 57.7% was girl (n=177) and 42.3% (n=130) boy. Of the 307 subjects 40 (13%) were classified as having MS. Serum AD levels were significantly lower in boys (p=0.02), and decreased while BMI increased, but this trend was not significant (p>0.05). Although median resistin values were higher in obese than others (20, 18.5, 17 ng/ml, respectively) it was not significant (p>0.05). In obese subjects, hs-CRP levels were significantly high (0.21 mg/L) (p=0.000). All three markers in obese and overweight children with and without MS were not significant (p>0.05). Girls with MS had lower adiponectin levels than those without MS. Waist circumference had the highest sensitivity and specificity for predicting MS in ROC analysis. The area under the curve (AUC) was 0.831 for WC standard error (SE) 0.033; 95% CI 0.767–0.896; p<0.0001. But the AUCs for the adiponectin, resistin, hs-CRP were not significant. In this study, we observed that adipokines or inflammatory markers have no predictive value in the diagnosis of MS. We concluded that the best marker for MS diagnosis is the measurement of waist circumference.

adipokines - adiponectin - resistin - hs-CRP - metabolic syndrome - obesity - schoolchildren - adolescents

References

• 1 Alberti KG, Zimmet P, Shaw J. for the IDF Epidemiology Task Force Consensus Group . The metabolic syndrome – a new worldwide definition.  Lancet. 2005;  366 1059-1062
• 2 Bahia L, Aguiar LG, Villela N. et al . Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome.  Clinics. 2006;  61 ((5)) 433-440
• 3 Bahia L, Aguiar LG, Villela N. et al . Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome.  Clinics. 2006;  61 ((5)) 433-440
• 4 Beltowski J. Adiponectin and resistin – new hormones of white adipose tissue.  Med Sci Monit. 2003;  9 ((2)) RA55-61
• 5 Böttner A, Kratzsch J, Müller G. et al . Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels.  J Clin Endocrinol Metab. 2004;  89 ((8)) 4053-4061
• 6 CDC (Centers for Disease Control and Prevention). . BMI for Children and Teens.  National Health and Nutrition Examination Survey. http://www cdc.gov/ , growth charts
• 7 Farvid MS, Ng TWK, Chan C. et al . Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidemia.  Diabetes Obes Metab. 2005;  7 ((4)) 406-413
• 8 Fernandez JR, Redden DT, Pietrobelli A. et al . Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents.  J Pediatr. 2004;  145 439-444
• 9 Ford ES, Ajani UA, Mokdad AH. National Health and Nutrition Examination . The metabolic syndrome and concentrations of C-reactive protein among US youth.  Diabetes Care. 2005;  28 ((4)) 878-881
• 10 Ford ES. C-reactive protein concentration and cardiovascular disease risk factors in children. Finding from the National Helth and Nutrition Examination Survey 1999–2000.  Circulation. 2003;  108 1053-1058
• 11 Gilardini L, MacTernan PG, Girola A. et al . Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents.  Atherosclerosis. 2006;  189 ((2)) 401-407
• 12 Hirschler V, Calcagno ML, Aranda C. et al . Can metabolic syndrome identify children with insulin resistance?.  Pediatr Diabetes. 2007;  8 272-277
• 13 Jarvisalo MJ, Harmoinen A, Hakanen M. et al . Elevated serum C-reactive protein levels and early arterial changes in healthy children.  Arterioscler Thromb Vasc Biol. 2002;  22 ((8)) 1323-1328
• 14 Kettaneh A, Heude B, Oppert JM. et al . Serum adiponectin is related to plasma high-density lipoprotein cholesterol but not to plasma insulin-concentration in healthy children: the FLVS II study.  Metabolism. 2006;  55 ((9)) 1171-1176
• 15 Lee JH, Chan JL, Yiannakouris N. et al . Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects.  J Clin Endocrinol Metab. 2003;  88 4848-4856
• 16 Lee S, Bacha F, Gungor N. et al . Comparision of different definitions of pediatric metabolic syndrome: Relation to abdominal adiposity, insulin resistance, adiponectin, and inflammatory biomarkers.  J Pediatr. 2008;  152 177-184
• 17 Lee S, Bacha F, Gungor N. et al . Racial differences in adiponectin in youth: relationship to visceral fat and insulin sensitivity.  Diabetes Care. 2006;  29 ((1)) 51-56
• 18 Lehrke M, Reilly MP, Millinton SC. et al . An inflammatory cascade leading to hyperresistinemia in humans.  Plos Med. 2004;  1 e45
• 19 Levinson SS, Miller JJ, Elin RJ. Poor predictive value of high-sensitivity C-reactive protein indicates need for reassessment.  Clin Chem. 2004;  50 ((10)) 1733-1735
• 20 Li L, Yang G, Li Q. et al . High-fat and lipid-induced insulin resistance in rats: The comparision of glucose metabolism, plasma resistin and adiponectin levels.  Ann Nutr Metab. 2006;  50 ((6)) 499-505
• 21 Libman MI, Arslanian SA. Prevention and treatment of type 2 diabetes in youth.  Horm Res. 2007;  67 22-34
• 22 Maffeis C, Banzato C, Talamini GM D. on behalf of The Obesity Study Group of The Italian Society of Pediatric Endocrinology and Diabetology . Waist-to-Height Ratio, a Useful Index to Identify High Metabolic Risk in Overweight Children.  J Pediatr. 2008;  152 207-213
• 23 Mangge H, Schauenstein K, Stroedter L. et al . Low grade inflammation in juvenile obesity and type 1 diabetes associated with early signs of atherosclerosis.  Exp Clin Endocrinol Diabetes. 2004;  112 ((7)) 378-382
• 24 Martos-Moreno GA, Barrios V, Argente J. Normative data for adiponectin, resistin, interleukin 6, and leptin/receptor ratio in a healthy Spanish pediatric population: relationship with sex steroids.  Eur J Endocrinol. 2006;  155 ((3)) 429-434
• 25 Mojiminiyi OA, Abdella NA, Al Arouj M. et al . Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with type 2 diabetes.  Int J Obes (Lond). 2007;  31 213-220
• 26 National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. . The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.  Pediatrics. 2004;  114 555-557
• 27 Nelson WE, Behrman RE, Kliegman RM. et al .Textbook of Pediatrics. Reference ranges chapter 710. 16th edn. USA: W.B. Saunders 2000: 2403-2413
• 28 Owecki M, Miczke A, Pupek-Musialik D. et al . Circulating serum adiponectin concentrations do not differ between obese and non-obese caucasians and are unrelated to insulin sensitivity.  Horm Metab Res. 2007;  39 ((1)) 25-30
• 29 Owecki M, Miczke A, Pupek-Musialik D. et al . Serum Adiponectin Concentrations are not Related to Glycosylated Hemoglobin Levels (HbA1c) in Obese Diabetic and Non-diabetic Caucasians.  Exp Clin Endocrinol Diabetes. 2008;  , Epub ahead
• 30 Patel L, Buckels AC, Kinghorn IJ. et al . Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators.  Biochem Biophys Res Commun. 2003;  300 472-476
• 31 Rea R, Donnelly R. Resistin: an adipocyte-derived hormone. Has it a role in diabetes and obesity?.  Diabetes, Obesity and Metab. 2004;  6 163-170
• 32 Schutte AE, Huisman HW, Schutte R. et al . Differences and similarities regarding adiponectin investigated in African and Caucasian women.  Eur J Endocrinol. 2007;  157 ((2)) 181-188
• 33 Shand B, Elder P, Scott R. et al . Comparion of plasma adiponectin levels in New Zealand Maori and Caucasian individuals.  N Z Med J. 2007;  120 ((1257)) U2606
• 34 Sun SS, Liang R, Huang TT. et al . Childhood obesity predicts adult metabolic syndrome: the Fels Longitudinal Study.  J Pediatr. 2008;  152 ((2)) 191-200
• 35 Ukkola O, Santaniemi M, Rankinen T. et al . Adiponectin polymorphisms, adiposity and insulin metabolism: HERITAGE family study and Oulu diabetic study.  Ann Med. 2005;  37 ((2)) 141-150
• 36 Utzchneider KM, Carr DB, Tong J. et al . Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans.  Diabetologia. 2005;  (48) 2330-2333
• 37 Valle JM, Estepa RM, Camacho RM. et al . Endothelial dysfunction is related to insulin resistance and inflammatory biomarker levels in obese prepubertal children.  Eur J Endocrinol. 2007;  156 ((4)) 497-502
• 38 Valle M, Martos R, Gascon F. et al . Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome.  Diabetes Metab. 2005;  31 55-62
• 39 Weiss R, Dziura J, Burgert TS. et al . Obesity and the metabolic syndrome in children and adolescents.  N Engl J Med. 2004;  350 2362-2374
• 40 Winer JC, Zern TL, Taksali SE. et al . Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome.  J Clin Endocrinol Metab. 2006;  91 ((11)) 4415-4423
• 41 World Health Organization .Physical Status: The Use and Interpretation of Anthropometry. Technical Report Series No. 854. WHO Geneva 1995
• 42 Yang WS, Lee WJ, Funahashi T. et al . Plasma adiponectin levels in overweight and obese Asians.  Obes Res. 2002;  10 ((11)) 1104-1110
• 43 Zimmet P, Alberti G, Kaufman F. et al . metabolic syndrome in children and adolescence.  The Lancet. 2007;  369 2059-2061

Correspondence